Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Transplant Hepatology
For remote liver transplant recipients back under the care of a community gastroenterologist (or PCP), what should be the approach to new liver enzyme elevations?
What should be ordered? Any medications given?
Related Questions
Is there a serum ammonium level for which you recommend initiation of dialysis in a patient with hepatic encephalopathy?
What would be the right patient profile and experience for someone who may have (operational) tolerance and how do you approach immunosuppresison management (or withdrawal) in this patient?
How would you workup a patient who develops ascites AFTER liver transplantation?
Having gone through multiple iterations, what MELD updates/considerations should we anticipate in the future?
What is your strategy to manage peri-procedural bleeding risk in patients with cirrhosis?
What graft and patient factors would increase the risk of early graft failure?
Should a patient who requires definitive treatment for prostate cancer as a pre-transplant requirement be strictly required to complete their course prior to transplant/initiation of immunosuppression?
How do you approach the evaluation of a living donor liver transplant candidate?
How much do you factor in a patient's frailty in selection for transplant if the underlying driver for their debility is their underlying liver disease itself?
For how long would you treat a patient with latent TB before allowing them to proceed with a liver transplant?